Invasive aspergillus infection of middle ear in a patient treated with secukinumab, methotrexate and corticosteroids for psoriasis and psoriatic arthritis
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F22%3A10445395" target="_blank" >RIV/00216208:11130/22:10445395 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11150/22:10445395 RIV/00179906:_____/22:10445395 RIV/00064211:_____/22:W0000010
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=uO7sec77eO" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=uO7sec77eO</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1080/09546634.2022.2104442" target="_blank" >10.1080/09546634.2022.2104442</a>
Alternative languages
Result language
angličtina
Original language name
Invasive aspergillus infection of middle ear in a patient treated with secukinumab, methotrexate and corticosteroids for psoriasis and psoriatic arthritis
Original language description
Mucocutaneous mycotic infections are common complications in patients on IL-17 inhibitor therapy. We report a case of a 33-year-old male with severe psoriasis and psoriatic arthritis on secukinumab combined with methotrexate and prednisone with swelling, otorrhoea and pain of the right ear and external auditory canal. Because of progressive hypacusis, a surgical solution was chosen. Tissue samples taken during surgery revealed the presence of Aspergillus fumigatus. Aspergillosis should be suspected in prolonged otorrhoea, especially in immunocompromised patients. Without intervention, the disease could be fatal.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30216 - Dermatology and venereal diseases
Result continuities
Project
<a href="/en/project/NU22J-05-00056" target="_blank" >NU22J-05-00056: The effect of anti IL-17 therapy on skin and gut microbiota and intestinal barrier function in psoriasis patients</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Dermatological Treatment
ISSN
0954-6634
e-ISSN
1471-1753
Volume of the periodical
33
Issue of the periodical within the volume
7
Country of publishing house
GB - UNITED KINGDOM
Number of pages
3
Pages from-to
3063-3065
UT code for WoS article
000831165000001
EID of the result in the Scopus database
2-s2.0-85135113637